معرفی
Harald Alfred Stenmark is a Professor at the University of Oslo's Faculty of Medicine, affiliated with the Institute of Clinical Medicine and the Centre for Cancer Cell Reprogramming (CanCell). His research focuses on cellular membrane dynamics, autophagy mechanisms, and ESCRT machinery, with applications to cancer biology and biomedical science. Stenmark leads studies on organelle interactions, including endosome-ER contact sites, migrasome formation, and autophagosome biogenesis.
His work integrates biochemistry, cell biology, and molecular genetics, addressing fundamental questions in membrane trafficking and disease mechanisms. Notable contributions include elucidating roles of phosphoinositides in cellular processes and discovering novel pathways in lysosomal repair and cancer cell invasiveness. Stenmark collaborates extensively with international teams, as evidenced by his co-authored publications in top journals like Nature Cell Biology and Cell Research.
Research interests span: autophagy regulation, cancer cell reprogramming, membrane contact site biology, and the role of phosphoinositides in cellular signaling. His lab's findings have implications for understanding cancer metastasis, neurodegenerative diseases, and immune cell function.
Stenmark is a key member of the CanCell research center, focusing on how cancer cells adapt their metabolism and signaling pathways. His work bridges basic science and translational research, with potential applications in developing therapeutic strategies targeting cellular reprogramming mechanisms.
